5kv8 - Revision history

OCA at 10:56, 27 September 2023

2023-09-27T10:56:43Z

←Older revision		Revision as of 10:56, 27 September 2023
Line 3:		Line 3:
	<StructureSection load='5kv8' size='340' side='right'caption='[[5kv8]], [[Resolution\|resolution]] 1.95Å' scene=''>		<StructureSection load='5kv8' size='340' side='right'caption='[[5kv8]], [[Resolution\|resolution]] 1.95Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5kv8]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Hpiv-3 Hpiv-~~3]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KV8 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=5KV8 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5kv8]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_respirovirus_3 Human respirovirus 3]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KV8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5KV8 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6Y6:2,6-anhydro-3,4,5-trideoxy-4-[4-(methoxymethyl)-1H-1,2,3-triazol-1-yl]-5-[(2-methylpropanoyl)amino]-D-glycero-D-galacto-non-2-enonic+acid'>6Y6</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NDG:2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE'>NDG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene~~></td></tr>~~	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.949Å</td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4xjq\|4xjq]], [[4xjr\|4xjr]], [[5kv9\|5kv9]]</td></tr>~~	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6Y6:2,6-anhydro-3,4,5-trideoxy-4-[4-(methoxymethyl)-1H-1,2,3-triazol-1-yl]-5-[(2-methylpropanoyl)amino]-D-glycero-D-galacto+-non-2-enonic+acid'>6Y6</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NDG:2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE'>NDG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5kv8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kv8 OCA], [https://pdbe.org/5kv8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5kv8 RCSB], [https://www.ebi.ac.uk/pdbsum/5kv8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5kv8 ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=5kv8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kv8 OCA], [~~http~~://pdbe.org/5kv8 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5kv8 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5kv8 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5kv8 ProSAT]</span></td></tr>	+
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/G8G134_9MONO G8G134_9MONO]
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 25:		Line 26:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Exo-alpha-sialidase]]~~	+	[[Category: Human respirovirus 3]]
-	~~[[Category: Hpiv-~~3]]	+
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Chavas~~, L M.G~~]]	+	[[Category: Chavas LMG]]
-	[[Category: Dirr, L]]	+	[[Category: Dirr L]]
-	[[Category: El-Deeb~~, I M~~]]	+	[[Category: El-Deeb IM]]
-	[[Category: Guillon, P]]	+	[[Category: Guillon P]]
-	[[Category: Itzstein, M ~~von]]~~	+	[[Category: Von Itzstein M]]
-	~~[[Category: Haemagglutinin-neuraminidase]]~~	+
-	~~[[Category: Host cell surface receptor binding]]~~	+
-	~~[[Category: Hydrolase]]~~	+
-	~~[[Category: Hydrolase-inhibitor complex]]~~	+
-	~~[[Category: Viral protein~~]]	+

OCA at 05:54, 22 April 2020

2020-04-22T05:54:27Z

←Older revision		Revision as of 05:54, 22 April 2020
Line 3:		Line 3:
	<StructureSection load='5kv8' size='340' side='right'caption='[[5kv8]], [[Resolution\|resolution]] 1.95Å' scene=''>		<StructureSection load='5kv8' size='340' side='right'caption='[[5kv8]], [[Resolution\|resolution]] 1.95Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5kv8]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Hpiv-3 Hpiv-3]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KV8 OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5KV8 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5kv8]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Hpiv-3 Hpiv-3]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KV8 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5KV8 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6Y6:(2~~~{R}~~,3~~~{R}~~,4~~~{S})~~-4-[4-(methoxymethyl)-1,2,3-triazol-1-yl]-3-(2-~~methylpropanoylamino~~)-2-~~[(1~{R},2~{R})~~-~~1,2,3~~-~~tris(oxidanyl)propyl]~~-~~3,4-dihydro~~-2~~~{H}-pyran-6~~-~~carboxylic~~+acid'>6Y6</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=~~NAG~~:N-~~ACETYL~~-D-~~GLUCOSAMINE~~'>~~NAG~~</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6Y6:2,6-anhydro-3,4,5-trideoxy-4-[4-(methoxymethyl)-1H-1,2,3-triazol-1-yl]-5-[(2-methylpropanoyl)amino]-D-glycero-D-galacto-non-2-enonic+acid'>6Y6</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NDG:2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE'>NDG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4xjq\|4xjq]], [[4xjr\|4xjr]], [[5kv9\|5kv9]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4xjq\|4xjq]], [[4xjr\|4xjr]], [[5kv9\|5kv9]]</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5kv8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kv8 OCA], [http://pdbe.org/5kv8 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5kv8 RCSB], [http://www.ebi.ac.uk/pdbsum/5kv8 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5kv8 ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5kv8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kv8 OCA], [http://pdbe.org/5kv8 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5kv8 RCSB], [http://www.ebi.ac.uk/pdbsum/5kv8 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5kv8 ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">

OCA at 09:02, 1 January 2020

2020-01-01T09:02:07Z

←Older revision		Revision as of 09:02, 1 January 2020
Line 1:		Line 1:

	==Crystal structure of a hPIV haemagglutinin-neuraminidase-inhibitor complex==		==Crystal structure of a hPIV haemagglutinin-neuraminidase-inhibitor complex==
-	<StructureSection load='5kv8' size='340' side='right' caption='[[5kv8]], [[Resolution\|resolution]] 1.95Å' scene=''>	+	<StructureSection load='5kv8' size='340' side='right'caption='[[5kv8]], [[Resolution\|resolution]] 1.95Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5kv8]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KV8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5KV8 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5kv8]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Hpiv-3 Hpiv-3]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KV8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5KV8 FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6Y6:(2~{R},3~{R},4~{S})-4-[4-(methoxymethyl)-1,2,3-triazol-1-yl]-3-(2-methylpropanoylamino)-2-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]-3,4-dihydro-2~{H}-pyran-6-carboxylic+acid'>6Y6</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6Y6:(2~{R},3~{R},4~{S})-4-[4-(methoxymethyl)-1,2,3-triazol-1-yl]-3-(2-methylpropanoylamino)-2-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]-3,4-dihydro-2~{H}-pyran-6-carboxylic+acid'>6Y6</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4xjq\|4xjq]], [[4xjr\|4xjr]], [[5kv9\|5kv9]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4xjq\|4xjq]], [[4xjr\|4xjr]], [[5kv9\|5kv9]]</td></tr>
Line 18:		Line 18:
	</div>		</div>
	<div class="pdbe-citations 5kv8" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 5kv8" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Hemagglutinin 3D structures\|Hemagglutinin 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
Line 23:		Line 26:
	</StructureSection>		</StructureSection>
	[[Category: Exo-alpha-sialidase]]		[[Category: Exo-alpha-sialidase]]
		+	[[Category: Hpiv-3]]
		+	[[Category: Large Structures]]
	[[Category: Chavas, L M.G]]		[[Category: Chavas, L M.G]]
	[[Category: Dirr, L]]		[[Category: Dirr, L]]

OCA at 10:14, 10 September 2017

2017-09-10T10:14:50Z

←Older revision		Revision as of 10:14, 10 September 2017
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 5kv8 is ~~ON HOLD until Paper~~ Publication	+	==Crystal structure of a hPIV haemagglutinin-neuraminidase-inhibitor complex==
		+	<StructureSection load='5kv8' size='340' side='right' caption='[[5kv8]], [[Resolution\|resolution]] 1.95Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[5kv8]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KV8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5KV8 FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6Y6:(2~{R},3~{R},4~{S})-4-[4-(methoxymethyl)-1,2,3-triazol-1-yl]-3-(2-methylpropanoylamino)-2-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]-3,4-dihydro-2~{H}-pyran-6-carboxylic+acid'>6Y6</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4xjq\|4xjq]], [[4xjr\|4xjr]], [[5kv9\|5kv9]]</td></tr>
		+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5kv8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kv8 OCA], [http://pdbe.org/5kv8 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5kv8 RCSB], [http://www.ebi.ac.uk/pdbsum/5kv8 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5kv8 ProSAT]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Human parainfluenza viruses represent a leading cause of lower respiratory tract disease in children, with currently no available approved drug or vaccine. The viral surface glycoprotein haemagglutinin-neuraminidase (HN) represents an ideal antiviral target. Herein, we describe the first structure-based study on the rearrangement of key active site amino acid residues by an induced opening of the 216-loop, through the accommodation of appropriately functionalised neuraminic acid-based inhibitors. We discovered that the rearrangement is influenced by the degree of loop opening and is controlled by the neuraminic acid's C-4 substituent's size (large or small). In this study, we found that these rearrangements induce a butterfly effect of paramount importance in HN inhibitor design and define criteria for the ideal substituent size in two different categories of HN inhibitors and provide novel structural insight into the druggable viral HN protein.

-	~~Authors~~:	+	The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design.,Dirr L, El-Deeb IM, Chavas LMG, Guillon P, Itzstein MV Sci Rep. 2017 Jul 3;7(1):4507. doi: 10.1038/s41598-017-04656-y. PMID:28674426<ref>PMID:28674426</ref>

-	~~Description~~:	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased Structures~~]]	+	</div>
		+	<div class="pdbe-citations 5kv8" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Exo-alpha-sialidase]]
		+	[[Category: Chavas, L M.G]]
		+	[[Category: Dirr, L]]
		+	[[Category: El-Deeb, I M]]
		+	[[Category: Guillon, P]]
		+	[[Category: Itzstein, M von]]
		+	[[Category: Haemagglutinin-neuraminidase]]
		+	[[Category: Host cell surface receptor binding]]
		+	[[Category: Hydrolase]]
		+	[[Category: Hydrolase-inhibitor complex]]
		+	[[Category: Viral protein]]

OCA at 13:47, 10 August 2016

2016-08-10T13:47:56Z

←Older revision		Revision as of 13:47, 10 August 2016
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5kv8 is ON HOLD	+	The entry 5kv8 is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "5kv8" [edit=sysop:move=sysop]

2016-07-26T12:59:00Z

Protected "5kv8" [edit=sysop:move=sysop]

←Older revision

Revision as of 12:59, 26 July 2016

OCA: New page: '''Unreleased structure''' The entry 5kv8 is ON HOLD Authors: Description: Category: Unreleased Structures

2016-07-26T12:58:58Z

New page: '''Unreleased structure''' The entry 5kv8 is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 5kv8 is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]